Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

3(43%)

Results Posted

25%(1 trials)

Phase Distribution

Ph phase_1

14%

Ph not_applicable

57%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

1(20.0%)

N/ANon-phased studies

4(80.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(4)

Detailed Status

Completed4

Active, not recruiting2

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (20.0%)

N/A4 (80.0%)

Trials by Status

recruiting114%

completed457%

active_not_recruiting229%

Recent Activity

3 active trials

Showing 5 of 7

active_not_recruitingnot_applicable

Clinical Trials (7)

Showing 7 of 7 trials

NCT05420233Not Applicable

The CROCO Study: CROhn's Disease COhort Study

Active Not Recruiting

NCT02230124Not Applicable

Magnetic Resonance Elastography in Hydrocephalus

Active Not Recruiting

NCT06779058

MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B

Recruiting

NCT05749198

Portal Hypertension Using Magnetic Resonance Elastography

Completed

NCT02423551Not Applicable

MRE Consumption and Gut Health

Completed

NCT01881490Not Applicable

The ImageKids Study: Developing the pMEDIC and the PICMI

Completed

NCT00896233Phase 1

Magnetic Resonance Elastography for Assessment of Liver Fibrosis (MK-0000-132)(COMPLETED)

Completed

All 7 trials loaded

Drug Details

Intervention Type: DIAGNOSTIC TEST
Total Trials: 7